Common D&O Mistakes Startups Make—and How to Avoid Them Before an IPO

Preparing for an IPO is one of the most demanding stretches in a startup’s lifecycle. For VC‑backed companies in the United States — especially in hubs like San Francisco Bay Area, New York City, Boston, and Seattle — Directors & Officers (D&O) liability becomes a top investor, board, and underwriter concern. Below are the most common D&O mistakes startups make, the real costs and market context, and practical steps to close coverage gaps before a listing.

Sources and market context:

Why D&O matters now (pre‑IPO)

  • Securities claims increase after listing — underwriters and IPO counsel demand robust D&O coverage and often require expanded Side A limits and IPO/transaction endorsements.
  • Investor requirements: VCs will typically require specific limits, endorsements, and insurer ratings to approve fund deployment or finalize purchase agreements. See investor‑focused guidance in our article Directors and Officers (D&O) Liability Insurance for Startups: Investor Requirements and Practical Tips.
  • Pricing volatility: The D&O market has hardened in recent cycles, increasing premiums and reducing available capacity for high‑risk private companies. Timing and broker strategy materially affect cost.

Top D&O mistakes startups make — and how to avoid them

1) Underinsuring (wrong limits for stage and investor expectations)

Mistake: Buying minimal limits (e.g., $1M/$1M aggregate) when investors or future underwriters will expect significantly higher Side A or aggregate limits.

How to avoid:

  • Benchmark by stage. Typical U.S. private‑company ranges (annual premium approximations):
    • Seed/pre‑seed: $3,000–$7,000 (for $1M–$5M limit structures)
    • Series A: $7,000–$25,000
    • Growth / Pre‑IPO: $25,000–$150,000+ depending on revenue, employee count, and transaction risk
      (Sources: Insureon; Fundera)
  • Negotiate Side A (individual director protection) with at least $2M–$5M on the path to an IPO; underwriters may request higher.

2) Overlooking the need for IPO/transaction coverage and endorsements

Mistake: Waiting until the IPO is filed to arrange transaction wording, loss‑notification extensions, or a D&O “run‑off” or “cut‑through” endorsement.

How to avoid:

3) Ignoring investor representation and insured v. insured carve‑backs

Mistake: Failing to secure language that protects directors against claims brought by significant investors or not negotiating insured v. insured exclusions.

How to avoid:

4) Late shopping in a hard market

Mistake: Waiting until you need coverage (or to satisfy a closing condition) — then accepting surprised higher premiums or limited capacity.

How to avoid:

  • Shop at least 90–180 days before you expect investor or underwriter sign‑offs.
  • Use experienced brokers who can access specialty D&O capacity (Beazley, Chubb, AIG, CNA, Hiscox are active in U.S. private‑company D&O markets).

5) Misunderstanding retentions, side limits, and who pays defense

Mistake: Confusion about Side A (non‑indemnifiable claims), Side B (company indemnification), and Side C (entity securities) coverage; choosing high retentions that expose founders personally.

How to avoid:

  • Ensure clear Side A limits that protect individual directors if the company cannot indemnify (critical in insolvency or bankruptcy scenarios).
  • Review retention levels (often $10k–$250k). Higher retentions lower premium but increase personal risk — calculate founder liquidity before accepting.

6) Inadequate disclosures leading to rescission or coverage denial

Mistake: Failing to disclose material facts (pending claims, regulatory inquiries, cyber breaches) on renewals or applications.

How to avoid:

  • Maintain disciplined disclosure practices and document internal investigations; consult coverage counsel before closing material events.
  • If there’s uncertainty about a potential claim, disclose it and obtain insurer acknowledgement rather than risk rescission later.

Practical pre‑IPO D&O checklist (actionable)

  • Engage a D&O broker 6–12 months pre‑IPO.
  • Obtain appetite letters and multiple insurer indications.
  • Increase Side A limits; consider Side A DIC if VCs require it.
  • Secure IPO/transaction endorsements and confirm run‑off options.
  • Negotiate insured v. insured carve‑backs and VC representation wording.
  • Confirm notice and consent procedures; ensure counsel reviews policy language.
  • Budget for a premium uplift — plan financing rounds accordingly.

Pricing snapshot and insurer examples (U.S. market)

Stage Typical annual premium (U.S., private startups) Typical retention Common insurers / notes
Seed / Pre‑seed $3,000 – $7,000 $10k – $50k Hiscox, CNA, small‑market programs (lower limits, basic Side A) (Insureon; Fundera)
Series A $7,000 – $25,000 $25k – $100k Chubb, Beazley, AIG — more appetite for tech and VC‑backed risks
Growth / Pre‑IPO $25,000 – $150,000+ $50k – $250k+ Larger placements, layered limits, IPO endorsements required

Notes:

  • These ranges are approximations; actual premiums depend on revenue, employee count, claim history, regulatory exposures, and transaction risk. (Sources: Insureon; Fundera)
  • Market conditions can change premiums rapidly; Aon and other market reports have documented recent rate increases in challenging cycles — budget accordingly. (See Aon market commentary)

When to escalate coverage or add endorsements

Final takeaways (for founders, GC, CFOs in the USA)

  • Start D&O planning early — 6–12 months before an expected IPO or major financing.
  • Use stage‑appropriate limits and retain experienced D&O brokers who know the VC market in San Francisco, NYC, Boston and Seattle.
  • Negotiate Side A protection, VC representations, insured v. insured carve‑backs, and IPO endorsements before you need them.
  • Budget realistic premiums and retentions; market cycles can spike costs and reduce capacity.

For a deeper investor‑oriented perspective and negotiation playbook, consult VC‑Driven D&O Demands: What Venture Capitalists Expect from Directors and Officers (D&O) Liability Insurance.

Sources:

Recommended Articles